跳至主要内容
临床试验/NCT02880280
NCT02880280Unknown4 期

Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin is Superior to Human Chorionic Gonadotropin in Therapeutic Efficacy in Adolescent Boys With Congenital Hypogonadotropic Hypogonadism

Beijing Children's Hospital1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2016年8月最近更新:
适应症
干预措施

试验速览

阶段
4 期
发起方
入组人数
40
试验地点
1
主要终点
testicular volume

研究概览

简要总结

Observe the therapeutic efficacy of human menopausal gonadotropin combining with human chorionic gonadotropin in adolescent boys with congenital hypogonadotropic hypogonadism.

详细描述

Observe safety and efficacy of human menopausal gonadotropin and human chorionic gonadotropin treating congenital hypogonadotropic hypogonadism in teenagers; which as clinic recommendation, may provide clinical basis for establishing standard treatment guideline in the future. Establish technological process and follow-up precept for human menopausal gonadotropin and human chorionic gonadotropin injection treating congenital hypogonadotropic hypogonadism in teenagers. And find safety and effective dose for teenagers.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
138 Months 至 18 Years(Child, Adult)
性别
Male
接受健康志愿者

入选标准

  • 未提供

排除标准

  • Any ascertain reason contributes to the non puberty development (Chromosome abnormal, trauma, surgeries) or any ascertain disease such as Prader-Willi syndrome or hypergonadotropic hypogonadism
  • Systemic diseases (such as chronic kidney failure, Mediterranean anemia, poor controlled diabetes)
  • Protein-energy malnutrition
  • Eating disorder (such as anorexia nervosa, binge eating)
  • Any brain diseases history: tumors in brain or pituitary or after their surgeries

研究组 & 干预措施

Human Menopausal Gonadotropin

Experimental

Human menopausal gonadotropin contains follicle-stimulating hormone (FSH) and luteinizing hormone (LH)

干预措施: Human Menopausal Gonadotropin (Drug)

Human Menopausal Gonadotropin

Experimental

Human menopausal gonadotropin contains follicle-stimulating hormone (FSH) and luteinizing hormone (LH)

干预措施: Human Chorionic Gonadotropin (Drug)

Human Chorionic Gonadotropin

Experimental

Human chorionic gonadotropin (hCG) is a hormone produced by the embryo after implantation

干预措施: Human Chorionic Gonadotropin (Drug)

结局指标

主要结局

testicular volume

时间窗: Change from Baseline testicular volume at 3 months after treatment

次要结局

  • The levels of testosterone serum (It were measured with chemiluminescent immunoassay Elecsys)(Testosterone changes from 3 months onwards after treatment compared to pretreatment)

研究者

发起方
Beijing Children's Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Chunxiu Gong

Professor

Beijing Children's Hospital

研究点 (1)

Loading locations...

相似试验